Vaksali Apteek OÜ
CopyRegistry data
Legal status
Company ID
14020851VAT code
EE101877695Registered
28/03/2016Share capital
2,500.00 €Activity
Retail sale of pharmaceutical products (47731 - EMTAK 2025)Contacts
Company registration address
Website
-
A
HighestReliability
A - Highest
0 ** during past year
Number of employees
1Credit limit
15-20 k €Credit report
Company's financial performance and creditability assessment.
-14.36 % ** during past year
Taxes
3.9KDebts
--25.22 % ** during past year
Taxable turnover
82.3K
Name, Surname  | Title | Start date | End date | Linkages |
|---|---|---|---|---|
Data is only provided to registered users with a legitimate interest. |
Financial ratios
Net Profit (€)
Register and
explore Okredo data
EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization and is a metric used to evaluate a company’s operating performance. It can be seen as a proxy for cash flow from the entire company’s operations.EBITDA margin (%)
Register and
explore Okredo dataEBIT margin shows the profitability of a company over a certain period of time.EBIT margin (%)
Register and
explore Okredo dataNet Profit (€)
Register and
explore Okredo dataEBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statement report (Okredo)
Premium users: 1.00 credit
| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€)Sales per employee is a popular efficiency indicator that is often used to measure a company's performance. The average annual number of employees is usually used to calculate the indicator. |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€)This ratio is on of company's growth indicators. It shows how much profit per employee is earned by the company. |
| Working capital requirement (%)The working capital requirement indicator shows how much funds a company needs to develop and maintain a business. |
| Debt-to-equity ratioThe debt-to-equity ratio is used to evaluate a company's financial leverage and is calculated by dividing a company’s total liabilities by its shareholder equity.
This ratio is a measure of the degree to which a company is financing its operations through debt versus wholly owned funds. More specifically, it reflects the ability of shareholder equity to cover all outstanding debts in the event of a business downturn. |
| EBITDA margin (%)EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization and is a metric used to evaluate a company’s operating performance. It can be seen as a proxy for cash flow from the entire company’s operations. |
| EBITDA (€)EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. Lenders use EBITDA to calculate a company’s ability to repay a loan and pay interest. |
| EBIT margin (%)EBIT margin shows the profitability of a company over a certain period of time. |
| EBIT (€)EBIT (earnings before interest and taxes) is a company's net income before income tax expense and interest expenses are deducted. EBIT is used to analyze the performance of a company's core operations without the costs of the capital structure and tax expenses impacting profit. |
| Total profitability (%)It is an indicator of company's performance efficiency, calculated as ratio of gross profit to sales revenue. |
| Net profitability (%)This ratio is commonly referred to as a company’s “bottom line” and is a true indicator of a company’s profitability. It shows how much a net profit of € 1 (or other monetary unit) is generated by sales. |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| Current Assets (€) |
| 2022 |
|---|
| 314,679 |
| 314,679 |
| 2,956 |
| 456 |
| 456 |
| 0.42 |
| 0.34 |
| 6.01 |
| 18,921 |
| 5.91 |
| 18,588 |
| 9.56 |
| 0.14 |
| 113,742 |
| 39,030 |
| 972 |
| 170,950 |
| 2023 |
|---|
| 385,438 |
| 385,438 |
| 19,645 |
| 12,105 |
| 12,105 |
| 0.17 |
| 0.57 |
| 13.39 |
| 51,604 |
| 13.30 |
| 51,271 |
| 10.48 |
| 3.14 |
| 65,847 |
| 37,858 |
| 639 |
| 103,066 |
| 2024 |
|---|
| 381,986 |
| 381,986 |
| 5,919 |
| 5,919 |
| 5,919 |
| 0.21 |
| 0.50 |
| 6.72 |
| 25,680 |
| 6.64 |
| 25,347 |
| 8.71 |
| 1.55 |
| 71,766 |
| 35,962 |
| 306 |
| 117,504 |
| 2024 |
|---|
| 381,986 |
| 381,986 |
| 5,919 |
| 5,919 |
| 5,919 |
| 0.21 |
| 0.50 |
| 6.72 |
| 25,680 |
| 6.64 |
| 25,347 |
| 8.71 |
| 1.55 |
| 71,766 |
| 35,962 |
| 306 |
| 117,504 |
Register and
explore Okredo dataTurnover (€)
Register and
explore Okredo dataCredit history
No. of unpaid debts
0
Largest debt
-
Amount of unpaid debts
€0.00
Oldest open debt
-
No. of unpaid debts
0
Largest debt
-
Amount of unpaid debts
€0.00
Oldest open debt
-
Credit report
Creditor/Data source | Debt amount | Debt date | Debt type |
|---|---|---|---|
- | - | - | - |
Creditor/Data source | Debt amount | Debt date | Payment date | Debt type |
|---|---|---|---|---|
- | - | - | - | - |
Credit report
It is a professional assessment of the company 's performance, revealing company's potential and risks, showing it's past experiences and revealing future prospects.
Example report (PDF)
Similar companies
Category:
Retail sale of pharmaceutical productsComp. code:
16495021Reg. date:
06/05/2022Turnover:
-No. of employees:
1Category:
Retail sale of pharmaceutical productsComp. code:
14853433Reg. date:
21/11/2019Turnover:
-No. of employees:
1Category:
Retail sale of pharmaceutical productsComp. code:
11441405Reg. date:
18/01/2008Turnover:
-No. of employees:
1Category:
Retail sale of pharmaceutical productsComp. code:
11335882Reg. date:
15/03/2007Turnover:
-No. of employees:
1Category:
Retail sale of pharmaceutical productsComp. code:
10694558Reg. date:
14/09/2000Turnover:
-No. of employees:
1